Following publication of the original article [1], the author identified an error in Figs. 6 and 9. The defined scale bars were provided.
Fig. 6
Suppressive effect of Pim-1 siRNA on the cell invasion in SACC cells. A. Crystal violet staining images of invasive SACC-83 and SACC-LM cells after Pim-1 siRNA transfection for 72 h. B. Quantification of the number of invaded SACC-83/SACC-LM in control siRNA and Pim-1 siRNA groups, respectively. Results were shownas mean ± SD. p < 0.05, *Pim-1 siRNA group compared with control siRNA group
Fig. 9
Immunohistochemical (IHC) staining of Pim-1 and RUNX3 in ACC. A. Negative Pim-IHC staining in ACC. B. Positive Pim-1 IHC staining in ACC. C. Negative RUNX3 IHC staining in ACC. D. Positive RUNX3 IHC staining in ACC. Magnificant factor: ×400.
×
×
The authors state that the image in Fig. 9C had been taken from the negative Pim-1 staining sample group in error. The corrected figure displays a representative image from the negative RUNX3 staining group.
This correction does not change the result, interpretation, and conclusions of the study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.
Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.
Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.
Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.
Update Onkologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
